4/24
08:07 am
inab
IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting [Yahoo! Finance]
Medium
Report
IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting [Yahoo! Finance]
4/24
08:00 am
inab
IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
Medium
Report
IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
4/16
04:29 pm
inab
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference [Yahoo! Finance]
Low
Report
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference [Yahoo! Finance]
4/16
04:05 pm
inab
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
Low
Report
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
4/10
12:46 pm
inab
Kill Leukemia Cells While Preserving Healthy Tissues: Nano-Cap Cancer Focused Firm IN8bio's Preclinical Candidate Shows Potential [Yahoo! Finance]
Medium
Report
Kill Leukemia Cells While Preserving Healthy Tissues: Nano-Cap Cancer Focused Firm IN8bio's Preclinical Candidate Shows Potential [Yahoo! Finance]
4/10
11:20 am
inab
IN8bio, Inc. (NASDAQ: INAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
Neutral
Report
IN8bio, Inc. (NASDAQ: INAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
4/10
09:58 am
inab
IN8bio gains after new preclinical data for nsCAR-T cell therapy platform [Seeking Alpha]
Low
Report
IN8bio gains after new preclinical data for nsCAR-T cell therapy platform [Seeking Alpha]
4/9
04:46 pm
inab
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024 [Yahoo! Finance]
High
Report
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024 [Yahoo! Finance]
4/9
04:30 pm
inab
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
Low
Report
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
3/28
09:28 am
inab
We're Keeping An Eye On IN8bio's (NASDAQ:INAB) Cash Burn Rate [Yahoo! Finance]
Medium
Report
We're Keeping An Eye On IN8bio's (NASDAQ:INAB) Cash Burn Rate [Yahoo! Finance]
3/18
03:04 pm
inab
IN8bio, Inc. (NASDAQ: INAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
Low
Report
IN8bio, Inc. (NASDAQ: INAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
3/18
08:19 am
inab
IN8bio, Inc. (NASDAQ: INAB) is now covered by analysts at Laidlaw. They set a "buy" rating and a $7.50 price target on the stock.
Low
Report
IN8bio, Inc. (NASDAQ: INAB) is now covered by analysts at Laidlaw. They set a "buy" rating and a $7.50 price target on the stock.
3/14
04:21 pm
inab
IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights [Yahoo! Finance]
Low
Report
IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights [Yahoo! Finance]
3/14
04:00 pm
inab
IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
Low
Report
IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
3/11
01:26 pm
inab
Cooley partner tapped to co-lead DLA Piper capital markets practice [Reuters]
Medium
Report
Cooley partner tapped to co-lead DLA Piper capital markets practice [Reuters]
3/5
04:43 pm
inab
IN8bio to Present New Preclinical Data on Novel Gamma-Delta CAR Platform Candidate at AACR Annual Meeting 2024 [Yahoo! Finance]
High
Report
IN8bio to Present New Preclinical Data on Novel Gamma-Delta CAR Platform Candidate at AACR Annual Meeting 2024 [Yahoo! Finance]
3/5
04:30 pm
inab
IN8bio to Present New Preclinical Data on Novel Gamma-Delta CAR Platform Candidate at AACR Annual Meeting 2024
High
Report
IN8bio to Present New Preclinical Data on Novel Gamma-Delta CAR Platform Candidate at AACR Annual Meeting 2024
2/26
08:18 am
inab
IN8bio to Present at Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
IN8bio to Present at Upcoming Investor Conferences [Yahoo! Finance]
2/26
08:00 am
inab
IN8bio to Present at Upcoming Investor Conferences
Low
Report
IN8bio to Present at Upcoming Investor Conferences
2/14
01:05 pm
inab
Gene and Cell Therapies Targeting CNS Disorders Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight [Yahoo! Finance]
Medium
Report
Gene and Cell Therapies Targeting CNS Disorders Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight [Yahoo! Finance]
2/14
08:10 am
inab
IN8bio Announces Publication on Novel Gamma-Delta T Cell Therapy for Glioblastoma in Frontiers in Immunology [Yahoo! Finance]
Medium
Report
IN8bio Announces Publication on Novel Gamma-Delta T Cell Therapy for Glioblastoma in Frontiers in Immunology [Yahoo! Finance]
2/14
08:00 am
inab
IN8bio Announces Publication on Novel Gamma-Delta T Cell Therapy for Glioblastoma in Frontiers in Immunology
Medium
Report
IN8bio Announces Publication on Novel Gamma-Delta T Cell Therapy for Glioblastoma in Frontiers in Immunology